Bone marrow biopsy in patients with plasma cell disorders

Angela Dispenzieri, MD, of the Mayo Clinic College of Medicine, Rochester, MN, discusses the prognostic value of bone marrow biopsies in patients with plasma cell disorders, as well as its use of minimal residual disease measurement. This interview was recorded via an online conference call with the Video Journal of Hematological Oncology (VJHemOnc).